William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Revance to Participate in the William Blair 42nd Annual Growth Stock Conference
-
William Blair Reiterates Revance Therapeutic (RVNC) at Outperform, Sees DAXI as a Blockbuster in the Making, Believes Approval is an Eventuality
-
Despite Prior Hiccups, Revance Therapeutic (RVNC) Could Launch DAXlin in Early 2023 - William Blair
-
Revance Therapeutics (RVNC) Defended at William Blair Following FDA Form 483
-
Revance to Participate in Upcoming Virtual Healthcare Conferences
-
Revance to Participate in the 40th Annual William Blair Growth Stock Conference
-
Companies with NDRs 10/01
-
Revance to Participate in Upcoming Investor Conferences
-
Revance Announces Closing of Public Offering of Common Stock
-
Revance Therapeutics (RVNC) Prices 5.34M Offering of Common Stock at $31/Share
-
Revance Announces Pricing of Public Offering of Common Stock
-
Revance to Participate in Upcoming Investor Conferences
-
Revance to Participate in Upcoming Investor Conferences
-
Revance Therapeutics Announces Closing of Public Offering of Common Stock
-
Revance Therapeutics (RVNC) Prices 3.25M Common Offering at $36/Share
-
Revance Therapeutics Announces Pricing of Public Offering of Common Stock
-
Revance Therapeutics (RVNC) Announces 3.25M Stock Offering
-
Revance Therapeutics Announces Proposed Public Offering of Common Stock
-
Revance to Participate in Upcoming Investor Conferences
-
William Blair Starts Revance Therapeutic (RVNC) at Outperform
-
Revance Therapeutics (RVNC) to Offer 3M Shares

